The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4+-Reference-Cited by-同舟云学术

The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4+

Published:2016-07 Issue:4 Volume:16 Page:632-639
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

García-Santos Esther Pilar,Padilla-Valverde David,Villarejo-Campos Pedro,Murillo-Lázaro Cristina,Fernández-Grande Esther,Palomino-Muñoz Teodoro,Rodríguez-Martínez Marta,Amo-Salas Mariano,Nuñez-Guerrero Paloma,Sánchez-García Susana,Puerto-Puerto Alejandro,Martín-Fernández Jesús

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Pancreatic cancer: translational research aspects and clinical implications;Ansari;WJS,2012

2. Cancer facts & figures;American Cancer Society,2013

3. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53;Mungamuri;Cancer Res,2006

4. Pancreatic cancer stem cells: fact or fiction?;Bhagwandin;Biochim Biophys Acta,2009

5. Stem cells, cancer, and cancer stem cells;Reya;Nature,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical safety study of a gemcitabine-controlled release polymer for locoregional administration in pancreatic cancer;Journal of Drug Delivery Science and Technology;2023-09

2. Extirpating the cancer stem cell hydra: Differentiation therapy and Hyperthermia therapy for targeting the cancer stem cell hierarchy;Clinical and Experimental Medicine;2023-04-24

3. Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-41;Journal of Gastrointestinal Oncology;2021-04

4. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial–Mesenchymal Transition;Cancer Research;2020-01-09

5. Clinicopathological significance and prognostic role of chemokine receptor CXCR4 expression in pancreatic ductal adenocarcinoma, a meta-analysis and literature review;International Journal of Surgery;2019-05